Pfizer, Gilead, GSK to lead infectious diseases market
Despite a 63.8 per cent decline in forecast sales for Covid-19 drugs in 2023, infectious disease drug sales are expected to maintain momentum going into the future…reports Asian Lite News Pharma giants